It has long been known that some constituents of the myelin sheaths of the central nervous system are metabolically stable (a half-life on the order of months or longer), while the more rapidly turning over constituents have a half-life on the order of days. Recently, we demonstrated that at least one constituent of the myelin sheath, the phosphate group which modifies basic proteins, turns over with a half-life on the order of minutes. Since very rapid turnover of a molecule is often related to functional significance, we have developed a research strategy to search for other very rapidly turning over components of the myelin sheath. We will also attempt to define any sub-myelin compartment (myelin sub-fraction) which may preferentially contain rapidly turning over myelin components. Knowledge of the type of components which turn over rapidly, and of their location, should serve as a clue as to the function of these molecules. Another probe of the dynamics of myelin membrane structure has to do with how rapidly the steroid components of myelin become available for exchange with cholestrol in other metabolic compartments. A research strategy involving treatment of young rats with hypercholesterolemic agents will be used to accumulate cholestrol precursors in the deveoping myelin membrane (7-dehydrocholesterol and desmosterol can replace much of normally appearing cholesterol). After termination of treatment the time course of the exchange of the cholesterol precursors with cholesterol in other membranes will be determined. Another area of myelin metabolism to be investigated is the role of the several possible pathways for biosynthesis of phosphatidylethanolamine. This lipid can be formed by decarboxylation of phosphatidylserine, by an exchange reaction in which ethanolamine replaces a pre-existing base moiety, or by a CDP-ethanolamine dependent synthesis. We will attempt to assess the contributions of these pathways to the synthesis of phosthatidylethanolamine of myelin (i.e. is one of these pathways preferentially represented in myelin forming cells?). The goal of the study is to gain an understanding of mechanisms involved in the formation and maintenance of the myelin sheath so that it can be better understood how specific pathological events can impair the formation of myelin or bring about degradation of formed myelin.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS011615-14
Application #
3394524
Study Section
Neurology B Subcommittee 1 (NEUB)
Project Start
1978-09-01
Project End
1987-08-31
Budget Start
1986-09-01
Budget End
1987-08-31
Support Year
14
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Jurevics, Helga; Hostettler, Janell; Sammond, Deanne W et al. (2003) Normal metabolism but different physical properties of myelin from mice deficient in proteolipid protein. J Neurosci Res 71:826-34
Jurevics, Helga; Largent, Carrie; Hostettler, Janell et al. (2002) Alterations in metabolism and gene expression in brain regions during cuprizone-induced demyelination and remyelination. J Neurochem 82:126-36
Jurevics, H; Hostettler, J; Muse, E D et al. (2001) Cerebroside synthesis as a measure of the rate of remyelination following cuprizone-induced demyelination in brain. J Neurochem 77:1067-76
Muse, E D; Jurevics, H; Toews, A D et al. (2001) Parameters related to lipid metabolism as markers of myelination in mouse brain. J Neurochem 76:77-86
Matsushima, G K; Morell, P (2001) The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 11:107-16
Mason, J L; Langaman, C; Morell, P et al. (2001) Episodic demyelination and subsequent remyelination within the murine central nervous system: changes in axonal calibre. Neuropathol Appl Neurobiol 27:50-8
Mason, J L; Jones, J J; Taniike, M et al. (2000) Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination. J Neurosci Res 61:251-62
Jurevics, H; Hostettler, J; Barrett, C et al. (2000) Diurnal and dietary-induced changes in cholesterol synthesis correlate with levels of mRNA for HMG-CoA reductase. J Lipid Res 41:1048-54
Goodrum, J F; Fowler, K A; Hostettler, J D et al. (2000) Peripheral nerve regeneration and cholesterol reutilization are normal in the low-density lipoprotein receptor knockout mouse. J Neurosci Res 59:581-6
Jurevics, H; Bouldin, T W; Toews, A D et al. (1998) Regenerating sciatic nerve does not utilize circulating cholesterol. Neurochem Res 23:401-6

Showing the most recent 10 out of 60 publications